Results 141 to 150 of about 41,093 (223)

Malaria vaccination and rebound malaria [PDF]

open access: yesThe Lancet Infectious Diseases, 2019
Dicko, Alassane, Greenwood, Brian
openaire   +2 more sources

Immune mechanisms targeting malaria transmission: opportunities for vaccine development

open access: yesExpert Review of Vaccines
Introduction Malaria continues to remain a major global health problem with nearly a quarter of a billion clinical cases and more than 600,000 deaths in 2022.
Geetha P. Bansal, Nirbhay Kumar
doaj   +1 more source

Next-Generation Vaccines Against Neglected Diseases: New Promises from Genetically Modified Live-Attenuated Parasites and RNA Vaccines

open access: yesMicroorganisms
Different protozoan parasites are the causative agents of tropical diseases, including malaria, toxoplasmosis, leishmaniasis, and Chagas disease (CD), which, altogether, affect over 300 million people throughout the world.
Marina Ferreira Batista-Zauli   +6 more
doaj   +1 more source

Current approaches to malaria vaccines. [PDF]

open access: yesCurr Opin Microbiol, 2022
Duffy PE.
europepmc   +1 more source

Atomic clarity: how structural biology is shaping blood-stage malaria vaccines. [PDF]

open access: yesTrans R Soc Trop Med Hyg
Nema S   +5 more
europepmc   +1 more source

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings. [PDF]

open access: yesFront Immunol
Bundi CK   +22 more
europepmc   +2 more sources

Malaria vaccines: Current developments and immunological insights. [PDF]

open access: yesNew Microbes New Infect
Verma A   +6 more
europepmc   +1 more source

Five decades of clinical assessment of whole-sporozoite malaria vaccines. [PDF]

open access: yesFront Immunol, 2022
Nunes-Cabaço H, Moita D, Prudêncio M.
europepmc   +1 more source

Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. [PDF]

open access: yesVaccines (Basel), 2021
Bonam SR   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy